STOCK TITAN

AVROBIO, Inc. Stock Price, News & Analysis

AVRO Nasdaq

Welcome to our dedicated page for AVROBIO news (Ticker: AVRO), a resource for investors and traders seeking the latest updates and insights on AVROBIO stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AVROBIO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AVROBIO's position in the market.

Rhea-AI Summary

Tectonic Therapeutic has appointed Daniel Lochner as its new Chief Financial Officer (CFO). Dan brings extensive experience in corporate finance, business strategy, and operations, particularly within the healthcare and biopharmaceutical industries. He has held significant roles at Viatris’ Eye Care Division and Oyster Point Pharma, as well as serving as a Managing Director and Equity Portfolio Manager at Goldman Sachs. Dan's appointment coincides with Tectonic's focus on developing GPCR-targeted therapeutic proteins. The outgoing CFO, Christian Cortis, will stay until early July to ensure a smooth transition and will later serve as a strategic advisor. Tectonic is also set to complete its merger with AVROBIO by the end of the month.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.72%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.06%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
45.96%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.1%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
69.01%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
45.33%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.99%
Tags
management

FAQ

What is the current stock price of AVROBIO (AVRO)?

The current stock price of AVROBIO (AVRO) is $1.4 as of February 7, 2025.

What is the market cap of AVROBIO (AVRO)?

The market cap of AVROBIO (AVRO) is approximately 62.9M.
AVROBIO, Inc.

Nasdaq:AVRO

AVRO Rankings

AVRO Stock Data

62.85M
44.89M
Biological Product (except Diagnostic) Manufacturing
Biological Products, (no Disgnostic Substances)
Link
US
CAMBRIDGE

AVRO RSS Feed